Literature DB >> 21913867

Modifying effect of arterial hypertension on amyotrophic lateral sclerosis.

Caroline Moreau1, Véronique Brunaud-Danel, Jean Dallongeville, Alain Duhamel, Laurence Laurier-Grymonprez, Jacques de Reuck, Anne Charlotte Wiart, Thierry Perez, Florence Richard, Philippe Amouyel, Régis Bordet, Luc Defebvre, Alain Destée, David Devos.   

Abstract

Given the high oxygen consumption of motor neurons, we sought to assess the frequency and prognostic value of arterial hypertension (affecting brain's oxygen supply) in amyotrophic lateral sclerosis (ALS). We consecutively and prospectively included all ALS patients with regular medical follow-up and documented blood pressure measurements and monitored them until death. Vascular factors diagnosed prior to the onset of motor signs in ALS patients were compared with those in a stratified, age- and gender-matched case-control population. The severity of leukoaraiosis on magnetic resonance imaging (MRI) was blindly assessed. Post mortem examinations were performed when authorized. Compared with controls (n = 408), the 102 ALS patients were significantly more likely to display hypertension (41-57%) and current smoking (15-26%). The number of years of hypertension was associated with survival (HR = 1.04 (1.01-1.07)). In a multivariate analysis, leukoaraiosis severity (HR = 1.214 (1.096-1.344)), current smoking (HR = 1.766 (1.085-2.872)) and low vital capacity (HR = 2.422 (1.266-4.633)) remained independent predictors of survival. Post mortem examinations revealed a greater frequency of leukoaraiosis in ALS patients (p = 0.02). In conclusion, the effect of chronic hypertension on survival might be exerted through abnormal neural perfusion. The higher frequency of recent hypertension in ALS patients may be due to a compensatory increase in blood pressure in response to a lower oxygen supply.

Entities:  

Mesh:

Year:  2011        PMID: 21913867     DOI: 10.3109/17482968.2011.610110

Source DB:  PubMed          Journal:  Amyotroph Lateral Scler        ISSN: 1471-180X


  6 in total

Review 1.  Medications on hypertension, hyperlipidemia, diabetes, and risk of amyotrophic lateral sclerosis: a systematic review and meta-analysis.

Authors:  Nan Hu; Hongyan Ji
Journal:  Neurol Sci       Date:  2022-05-26       Impact factor: 3.830

Review 2.  Potential new complication in drug therapy development for amyotrophic lateral sclerosis.

Authors:  Svitlana Garbuzova-Davis; Avery Thomson; Crupa Kurien; R Douglas Shytle; Paul R Sanberg
Journal:  Expert Rev Neurother       Date:  2016-07-15       Impact factor: 4.618

3.  Predicting disease risk using bootstrap ranking and classification algorithms.

Authors:  Ohad Manor; Eran Segal
Journal:  PLoS Comput Biol       Date:  2013-08-22       Impact factor: 4.475

4.  Assessing the role of blood pressure in amyotrophic lateral sclerosis: a Mendelian randomization study.

Authors:  Tao Huang; Dongsheng Fan; Kailin Xia; Linjing Zhang; Lu Tang
Journal:  Orphanet J Rare Dis       Date:  2022-02-16       Impact factor: 4.123

5.  Antecedent Disease and Amyotrophic Lateral Sclerosis: What Is Protecting Whom?

Authors:  Sabrina K Hollinger; Ike S Okosun; Cassie S Mitchell
Journal:  Front Neurol       Date:  2016-03-29       Impact factor: 4.003

Review 6.  Defining novel functions for cerebrospinal fluid in ALS pathophysiology.

Authors:  Koy Chong Ng Kee Kwong; Arpan R Mehta; Maiken Nedergaard; Siddharthan Chandran
Journal:  Acta Neuropathol Commun       Date:  2020-08-20       Impact factor: 7.801

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.